Organization Full Program · Contributors · Organizations · Search Program · My Schedule · Happening NowMore…Search ProgramMy ScheduleHappening NowMassachusetts General BrighamContributorsMerit CudkowiczPresentationsGeneral SessionThe ExTINGUISH Trial: A Phase-2B randomized placebo-controlled trial of inebilizumab in anti-NMDA receptor encephalitis CNS Infections/Inflammatory
